Eastman Chemical
EMN NYSE· Specialty Chemicals
Last close · Oct 26, 2026
$65.73
KIRA · Stoqly’s AI analyst, in plain words
- Eastman Chemical had $8.8B of revenue in fiscal 2025, down 6.7% on the year before. Over five years, revenue changed +0.7% a year on average.
- Eastman Chemical made $474M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew −3.7% a year.
- Free cash flow was $424M in fiscal 2025, 4.8% of revenue.
- Eastman Chemical returned $381M to shareholders in fiscal 2025, 90% of free cash flow. The diluted share count fell 2.0%.
- Eastman Chemical owes $4.2B more than it holds in cash, about 3.3 years of operating profit.
Market cap
$7.6B
P/E
17.1x
Revenue
$8.8B
Net income
$474M
Free cash flow
$424M
Operating margin
—
Eastman Chemical in 30 seconds · fiscal 2025
Are sales growing?
−6.7%
No. Sales fell 6.7% last year.
Does it make a profit?
5.4%
A little. It keeps 5.4% of every sale as profit.
Does profit turn into cash?
4.8%
Partly. 4.8% of sales ends up as free cash.
Is debt under control?
3.3x
Heavy. Repaying its debt would take 3.3 years of operating profit.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
How is the share priced?
17.1x
One share costs 17.1 times its yearly profit per share. Typical for its sector: 20.6x.
What Eastman Chemical does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 13, 2026
- Legal name
- EASTMAN CHEMICAL CO
- CIK
- 0000915389
Eastman Chemical · EMN
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $10.5B | $10.6B | $9.2B | $9.4B | $8.8B |
| Revenue growth | 23.6% | 1.0% | −13.0% | 1.9% | −6.7% |
| Gross margin | 23.9% | 20.2% | 22.4% | 24.4% | 21.1% |
| Net income | $857M | $793M | $894M | $905M | $474M |
| Net margin | 8.2% | 7.5% | 9.7% | 9.7% | 5.4% |
| Diluted EPS | $6.25 | $6.35 | $7.49 | $7.67 | $4.10 |
| Cash | |||||
| Cash from operations | $1.6B | $975M | $1.4B | $1.3B | $970M |
| Capital expenditure | $555M | $611M | $828M | $599M | $546M |
| Free cash flow | $1.1B | $364M | $546M | $688M | $424M |
| FCF margin | 10.2% | 3.4% | 5.9% | 7.3% | 4.8% |
| Dividends paid | $375M | $381M | $376M | $379M | $381M |
| Share buybacks | $900M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share count change | 0.4% | −8.9% | −4.4% | −1.3% | −2.0% |
| Debt and strength | |||||
| Cash and short-term investments | $459M | $493M | $548M | $837M | $566M |
| Debt incl. finance leases | $5.2B | $5.2B | $4.8B | $5.0B | $4.8B |
| Shareholders' equity | $5.7B | $5.2B | $5.5B | $5.8B | $6.0B |
| Net debt / EBITDA | 2.6x | 2.9x | 2.4x | 2.3x | 3.3x |
| Current ratio | 1.6x | 1.2x | 1.4x | 1.5x | 1.4x |
| Interest coverage | 7.4x | 6.5x | 6.1x | 6.3x | 3.6x |
| Returns and quality | |||||
| Return on capital | 9.3% | 9.2% | 10.9% | 10.9% | 6.5% |
| Return on equity | 14.6% | 14.6% | 16.9% | 16.1% | 8.1% |
| Piotroski F-score | 7 | 5 | 8 | 8 | 5 |
| Altman Z'' | 3.7 | 3.3 | 3.8 | 4.0 | 3.7 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.4M
1 insider
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Eastman Chemical · EMN
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| Eastman Chemical EMN | $7.6B | −6.7% | — | 4.8% | 6.5% | 17.1x | 5 |
| Celanese CE | $5.3B | −7.1% | −8.2% | 8.4% | −3.7% | — | 5 |
| RPM International RPM | $12.5B | 6.7% | — | 8.6% | 13.9% | 18.1x | 6 |
| International Flavors & Frag... IFF | $24.1B | −5.2% | −3.5% | 2.4% | −1.4% | 82.2x | 6 |
| Westlake WLK | $8.4B | −8.0% | −14.1% | −4.7% | −10.0% | — | 3 |
Price compared with profit (P/E)
How many times its yearly profit per share one share costs. Higher means investors pay more for each unit of profit.
KIRA
At $65.73 a share, the company is worth $7.6B: 17.1 times its earnings of the last four quarters.
Eastman Chemical grew sales faster than 2 of its 4 similar companies. Its P/E is higher than 0 of 2.
Source: SEC EDGAR XBRL filings (CIK 0000915389). Data updated October 12, 2026. For information only — not investment advice. Check the original filings before relying on any figure.